Amanda J. Linke

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer”.

STAT3 in tumor fibroblasts promotes an immunosuppressive microenvironment in pancreatic cancer

Life Science Alliance(2022)10.26508/lsa.202201460

N/A

0DataRank · unranked

49 citations

Catherine B. MarElia, Katie Thies, Blake E. Hildreth, Sudarshana M. Sharma, Jason R. Pitarresi +16 more

In situ modeling of acquired resistance to RTK/RAS-pathway-targeted therapies

iScience(2023)10.1016/j.isci.2023.108711

N/A

0DataRank · unranked

15 citations

Patricia L. Theard, Jacob M. Hughes, Amanda J. Linke, Brianna R. Daley, Robert L. Kortum +1 more

SOS2 modulates the threshold of EGFR signaling to regulate osimertinib efficacy and resistance in lung adenocarcinoma

Molecular Oncology(2023)10.1002/1878-0261.13564

N/A

0DataRank · unranked

14 citations

Amanda J. Linke, Nancy E. Sealover, Brianna R. Daley, Johnny Yang, Katherine Cox +2 more

SOS1 inhibition enhances the efficacy of and delays resistance to G12C inhibitors in lung adenocarcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.07.570642

N/A

0DataRank · unranked

6 citations

Nancy E. Sealover, Erin Sheffels, Jacob M. Hughes, Daniel Gerlach, Marco H. Hofmann +8 more

SOS2 regulates the threshold of mutant EGFR -dependent oncogenesis

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.20.524989

N/A

0DataRank · unranked

3 citations

Amanda J. Linke, Nancy E. Sealover, Brianna R. Daley, Johnny Yang, Katherine Cox +2 more

In situ modeling of acquired resistance to RTK/RAS pathway targeted therapies

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.27.525958

N/A

0DataRank · unranked

2 citations

Patricia T. Theard, Amanda J. Linke, Jacob M. Hughes, Brianna R. Daley, Robert L. Kortum +1 more

SOS1 Inhibition Enhances the Efficacy of KRASG12C Inhibitors and Delays Resistance in Lung Adenocarcinoma

Cancer Research(2024)10.1158/0008-5472.can-23-3256

N/A

0DataRank · unranked

13 citations

Nancy E. Sealover, Bridget A. Finniff, Jacob M. Hughes, Erin Sheffels, Daniel Gerlach +11 more

Protocol for modeling acquired resistance to targeted therapeutics in adherent and suspension cancer cell lines via in situ resistance assay

STAR Protocols(2024)10.1016/j.xpro.2024.103361

N/A

0DataRank · unranked

6 citations

Jacob M. Hughes, Patricia L. Theard, Deepan Chatterjee, Amanda J. Linke, Bridget A. Finniff +4 more

Wild-type RAS signaling is an essential therapeutic target in RAS -mutated cancers

Science Signaling(2025)10.1126/scisignal.adx5186

N/A

0DataRank · unranked

4 citations

Bridget A. Finniff, Jacob M. Hughes, Erin Sheffels, Hyun Lee, Joseph P. LaMorte +7 more